Skip to main content
Premium Trial:

Request an Annual Quote

IsoPlexis: Nachum Shamir, Siddhartha Kadia, Michael Egholm

IsoPlexis has appointed Nachum "Homi" Shamir to its board of directors as a class II director. Shamir was most recently chairman and CEO of Luminex from 2014 through its sale to DiaSorin in 2021. Previously, Shamir was president and CEO of Given Imaging from 2006 through its sale to Covidien (now Medtronic) in 2014. Shamir currently serves on the board of directors of Strata Skin Sciences and as chairman of the boards of Mediwound and Cactus Acquisition.

IsoPlexis also said that it has accepted the resignations of Siddhartha Kadia and Michael Egholm from its board. IsoPlexis will continue to search for an additional board member and expects to fill this opening prior to its next annual meeting.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.